推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Osteomacs are critical for optimal intramembranous bone formation in a tibial defect model of bone healing

KA Alexander, L Raggatt, M Chang… - … Society of Bone …, 2011 - espace.library.uq.edu.au
Osteal tissues contain a resident population of macrophages (osteomacs) and in vitro these cells
regulate osteoblast mineralisation. In vivo osteomacs form a canopy structure covering osteoblast
bone forming surfaces (ObS) and depletion of osteomacs, using the Macrophage-Fas- ...
Cited by 1 - Related articles - Cached - All 4 versions

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three‐year continued therapy and resolution of effect

JA Eisman, HG Bone, DJ Hosking… - Journal of Bone and …, 2011 - Wiley Online Library
Page 1. Original Article Odanacatib in the Treatment of Postmenopausal Women with Low
Bone Mineral Density: Three-year Continued Therapy and Resolution of Effect John A.
Eisman MBBS, Ph.D.1, Henry G. Bone, MD2, David J. Hosking, MD3, ...
Cited by 15 - Related articles - All 3 versions

Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass

HG Bone, MA Bolognese, CK Yuen… - Journal of Clinical …, 2011 - Endocrine Soc
Context: Denosumab treatment for 24 months increased bone mineral density (BMD) and reduced
bone turnover markers (BTM) in postmenopausal women. ... Objective: The aim was to determine
the effects of prior denosumab or placebo injections on BMD, BTM, and safety over 24 ...
Cited by 8 - Related articles - All 3 versions

Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia

B Bragdon, S Thinakaran, O Moseychuk, L Gurski… - Bone, 2011 - Elsevier
We previously identified Protein Kinase CK2 to interact with BMP receptor type Ia (BMPRIa) and
as a key protein for signal activation. Peptides approximately 30 AA were developed that mimicked
BMP2 action in vitro by blocking this interaction. In this paper we extended our studies to ...

… , a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral …

[PDF] from ued-ham.org.br…, DN Gordon, S Papapoulos, HG Bone… - Journal of Clinical …, 2011 - Endocrine Soc
Page 1. The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone
Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women
with Low Bone Mineral Density Lorraine A. Fitzpatrick ...
Cited by 1 - Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451